The search found 2 results in 0.084 seconds.
Finding ways of curbing government expenditure on the PBS while maintaining social equity and access to 'essential' medicines is at the centre of ongoing public debate. This paper outlines future developments that will extend the current model to include health outcomes. Adding health outcomes represents...
In recent years outlays on the Pharmaceutical Benefits Scheme have increased rapidly, prompting both attempts by government to reduce growth in outlays and renewed interest in the characteristics of the beneficiaries of the Scheme. This paper, using a microsimulation model of the PBS, analyses the...